lexiscan(r) (regadenoson)
Generic: lexiscan(r) (regadenoson)
Labeler: hf acquisition co llc, dba healthfirstDrug Facts
Product Profile
Brand Name
lexiscan(r) (regadenoson)
Generic Name
lexiscan(r) (regadenoson)
Labeler
hf acquisition co llc, dba healthfirst
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
regadenoson .08 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
51662-1448
Product ID
51662-1448_0ffbfae4-66b6-b616-e063-6294a90a2d06
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA022161
Listing Expiration
2026-12-31
Marketing Start
2019-12-10
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
516621448
Hyphenated Format
51662-1448
Supplemental Identifiers
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lexiscan(r) (regadenoson) (source: ndc)
Generic Name
lexiscan(r) (regadenoson) (source: ndc)
Application Number
NDA022161 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .08 mg/mL
Packaging
- 1 SYRINGE, PLASTIC in 1 CARTON (51662-1448-1) / 5 mL in 1 SYRINGE, PLASTIC
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "0ffbfae4-66b6-b616-e063-6294a90a2d06", "openfda": {"nui": ["N0000178375", "N0000175788"], "unii": ["2XLN4Y044H"], "spl_set_id": ["99640071-4db2-9317-e053-2995a90a610d"], "pharm_class_epc": ["Adenosine Receptor Agonist [EPC]"], "pharm_class_moa": ["Adenosine Receptor Agonists [MoA]"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, PLASTIC in 1 CARTON (51662-1448-1) / 5 mL in 1 SYRINGE, PLASTIC", "package_ndc": "51662-1448-1", "marketing_start_date": "20191210"}], "brand_name": "LEXISCAN(R) (REGADENOSON)", "product_id": "51662-1448_0ffbfae4-66b6-b616-e063-6294a90a2d06", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adenosine Receptor Agonists [MoA]", "Pharmacologic Cardiac Stress Test Agent [EPC]"], "product_ndc": "51662-1448", "generic_name": "LEXISCAN(R) (REGADENOSON)", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LEXISCAN(R) (REGADENOSON)", "active_ingredients": [{"name": "REGADENOSON", "strength": ".08 mg/mL"}], "application_number": "NDA022161", "marketing_category": "NDA", "marketing_start_date": "20191210", "listing_expiration_date": "20261231"}